Lezaic, L. et al. 2024. [18F]fluorocholine PET vs [99mTc]sestamibi scintigraphy in patients with primary hyperparathyroidism: outcomes and resource efficiency. Radiology and Oncology. 58, 4 (Nov. 2024), 486–493.